The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis
Background: Sexual function is often impaired following neurological disorders such as multiple sclerosis (MS). Young women with MS encourage disruptions in sexual function, sexual behaviors, and family formation as common global problems. Thus, the aim of the present systematic review and meta-anal...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Published: |
Springer Science and Business Media LLC
2022
|
_version_ | 1825939823975727104 |
---|---|
author | Salari, Nader Hasheminezhad, Razie Abdolmaleki, Amir Kiaei, Aliakbar Razazian, Nazanin Shohaimi, Shamarina Mohammadi, Masoud |
author_facet | Salari, Nader Hasheminezhad, Razie Abdolmaleki, Amir Kiaei, Aliakbar Razazian, Nazanin Shohaimi, Shamarina Mohammadi, Masoud |
author_sort | Salari, Nader |
collection | UPM |
description | Background: Sexual function is often impaired following neurological disorders such as multiple sclerosis (MS). Young women with MS encourage disruptions in sexual function, sexual behaviors, and family formation as common global problems. Thus, the aim of the present systematic review and meta-analysis study was to investigate the global prevalence of female sexual dysfunction (FSD) worldwide. Methods: Various databases (PubMed, Scopus, Web of Science, Embase, and ScienceDirect) along with Google Scholar search engine were hired for systematic searching in the field of the prevalence of FSD (by July 2022). The heterogeneity of the studies was assessed using I2 index, and random effects model was used to perform the analysis (CMA software, v.2). Results: Following assessment of 14 included studies with the sample size of 2115 women, a total prevalence of sexual dysfunction (SD) in women with MS was reported 62.5 (95 CI 53.9–70.5). Meta-regression assessment also showed that FSD accelerates following increasing the sample size and the year of the studies. Conclusion: The total prevalence of SD in women with MS was found considerably high (62.5) in the world, which needs more serious attention by health policymakers. Correct implementation of health policies can potentially increase the society’s awareness and successful treatment of SD in MS patients |
first_indexed | 2024-09-25T03:42:39Z |
format | Article |
id | upm.eprints-110167 |
institution | Universiti Putra Malaysia |
last_indexed | 2024-09-25T03:42:39Z |
publishDate | 2022 |
publisher | Springer Science and Business Media LLC |
record_format | dspace |
spelling | upm.eprints-1101672024-09-04T04:16:45Z http://psasir.upm.edu.my/id/eprint/110167/ The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis Salari, Nader Hasheminezhad, Razie Abdolmaleki, Amir Kiaei, Aliakbar Razazian, Nazanin Shohaimi, Shamarina Mohammadi, Masoud Background: Sexual function is often impaired following neurological disorders such as multiple sclerosis (MS). Young women with MS encourage disruptions in sexual function, sexual behaviors, and family formation as common global problems. Thus, the aim of the present systematic review and meta-analysis study was to investigate the global prevalence of female sexual dysfunction (FSD) worldwide. Methods: Various databases (PubMed, Scopus, Web of Science, Embase, and ScienceDirect) along with Google Scholar search engine were hired for systematic searching in the field of the prevalence of FSD (by July 2022). The heterogeneity of the studies was assessed using I2 index, and random effects model was used to perform the analysis (CMA software, v.2). Results: Following assessment of 14 included studies with the sample size of 2115 women, a total prevalence of sexual dysfunction (SD) in women with MS was reported 62.5 (95 CI 53.9–70.5). Meta-regression assessment also showed that FSD accelerates following increasing the sample size and the year of the studies. Conclusion: The total prevalence of SD in women with MS was found considerably high (62.5) in the world, which needs more serious attention by health policymakers. Correct implementation of health policies can potentially increase the society’s awareness and successful treatment of SD in MS patients Springer Science and Business Media LLC 2022 Article PeerReviewed Salari, Nader and Hasheminezhad, Razie and Abdolmaleki, Amir and Kiaei, Aliakbar and Razazian, Nazanin and Shohaimi, Shamarina and Mohammadi, Masoud (2022) The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis. Neurological Sciences, 44 (1). 59- 66. ISSN 1590-1874; ESSN: 1590-3478 https://link.springer.com/article/10.1007/s10072-022-06406-z?error=cookies_not_supported&code=d698edbb-be80-4454-89ca-c473ae4e6705 10.1007/s10072-022-06406-z |
spellingShingle | Salari, Nader Hasheminezhad, Razie Abdolmaleki, Amir Kiaei, Aliakbar Razazian, Nazanin Shohaimi, Shamarina Mohammadi, Masoud The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title | The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title_full | The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title_fullStr | The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title_full_unstemmed | The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title_short | The global prevalence of sexual dysfunction in women with multiple sclerosis: a systematic review and meta-analysis |
title_sort | global prevalence of sexual dysfunction in women with multiple sclerosis a systematic review and meta analysis |
work_keys_str_mv | AT salarinader theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT hasheminezhadrazie theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT abdolmalekiamir theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT kiaeialiakbar theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT razaziannazanin theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT shohaimishamarina theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT mohammadimasoud theglobalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT salarinader globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT hasheminezhadrazie globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT abdolmalekiamir globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT kiaeialiakbar globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT razaziannazanin globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT shohaimishamarina globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis AT mohammadimasoud globalprevalenceofsexualdysfunctioninwomenwithmultiplesclerosisasystematicreviewandmetaanalysis |